These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3242191)

  • 1. High-dose intravenous methylprednisolone in the treatment of acute nonlymphoblastic leukemia with ocular involvement.
    Hiçsönmez G; Ozsoylu S; Tuncer M; Erer B
    Turk J Pediatr; 1988; 30(3):181-3. PubMed ID: 3242191
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of ocular leukemia with local chemotherapy.
    Rootman J; Gudauskas G
    Cancer Treat Rep; 1985 Jan; 69(1):119-22. PubMed ID: 3855383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose methylprednisolone for acute nonlymphoblastic leukemia.
    Hiçsönmez G; Ozsoylu S
    Exp Hematol; 1989 Nov; 17(10):1051-2. PubMed ID: 2806437
    [No Abstract]   [Full Text] [Related]  

  • 4. Myeloprotective effect of short-course high-dose methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia.
    Elmas SA; Cetin M; Tuncer M; Hiçsönmez G
    Am J Hematol; 2005 Sep; 80(1):1-5. PubMed ID: 16138333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.
    Miyawaki S; Kobayashi T; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Omoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Ueda T; Tomonaga M; Ohno R
    Int J Hematol; 1999 Jul; 70(1):56-7. PubMed ID: 10446497
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytarabine-induced neurotoxicity responding to methyl prednisolone.
    Malhotra P; Mahi S; Lal V; Kumari S; Jain S; Varma S
    Am J Hematol; 2004 Dec; 77(4):416. PubMed ID: 15551283
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of poor prognosis acute myeloid leukemia with aggressive and non-aggressive chemotherapy.
    Stenke L; Hast R; Reizenstein P
    Chemioterapia; 1987 Jun; 6(2 Suppl):723-4. PubMed ID: 3509530
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
    Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
    J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose methylprednisolone in children with acute nonlymphoblastic leukemia.
    Hiçsönmez G; Ozsoylu S
    Am J Hematol; 1990 Dec; 35(4):288-9. PubMed ID: 2239928
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside].
    Patterson D; Kravtsova VM; Petrova EM; Zabelina TS; Balaian LN
    Ter Arkh; 1987; 59(12):81-6. PubMed ID: 3482131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
    Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H
    Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols.
    Khattab TM; Atra AA; Elimam NA; Kassar A; Zayed A; Baothman A
    Saudi Med J; 2008 May; 29(5):776-7. PubMed ID: 18454233
    [No Abstract]   [Full Text] [Related]  

  • 13. Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.
    Camera A; Rinaldi CR; Palmieri S; Cantore N; Mele G; Mettivier V; Miraglia E; Mastrullo L; Grimaldi F; Luciano L; Guerriero A; Rotoli B; Ferrara F
    Ann Hematol; 2009 Feb; 88(2):151-8. PubMed ID: 18709502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia.
    Yalman N; Sarper N; Devecioğlu O; Anak S; Eryilmaz E; Can M; Yenilmez H; Ağaoğlu L; Gedikoğlu G
    Turk J Pediatr; 2000; 42(3):198-204. PubMed ID: 11105617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curing acute myelogenous leukemia: still a major challenge.
    Smith BD; Karp JE
    Leuk Res; 2005 Jun; 29(6):607-8. PubMed ID: 15863198
    [No Abstract]   [Full Text] [Related]  

  • 16. The results of treatment with idarubicin in childhood acute nonlymphoblastic leukemia.
    Saşmaz I; Tanyeli A; Bayram I; Antmen B; Yilmaz L; Küçükosmanoğlu O; Kilinç Y
    Turk J Pediatr; 2004; 46(1):32-7. PubMed ID: 15074372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of acute myeloid leukemia].
    Obrecht JP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(2):190-200. PubMed ID: 6208102
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia.
    Decker RW; Ho WG; Champlin RE
    Cancer Treat Rep; 1987 Sep; 71(9):881-2. PubMed ID: 3476204
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of short course of high-dose methylprednisolone in children with acute myeloblastic leukemia (FAB M2) presented with myeloid tumor.
    Hiçsönmez G; Cetin M; Aslan D; Ozyürek E
    Pediatr Hematol Oncol; 2003; 20(5):373-9. PubMed ID: 12775535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the effect of cellular morphology on obtaining a complete remission in 99 cases of acute leukemia].
    Ríos A; Rozman C; Del Cañizo MC; Brugués R
    Sangre (Barc); 1984; 29(3):273-9. PubMed ID: 6592764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.